<p>拥有大量资金的投资者对 <strong>礼来</strong> (NYSE: LLY) 持悲观态度。</p>
<p>而散户交易者应该知道这一点。</p>
<p>我们今天注意到这一点，当交易出现在我们在 Benzinga 跟踪的公开可用期权历史中时。</p>
<p>我们不知道这些是机构还是仅仅是富有的个人。但当 LLY 发生如此重大的事情时，通常意味着有人知道即将发生什么。</p>
<p>那么我们如何知道这些投资者刚刚做了什么呢？</p>
<p>今天，Benzinga 的期权扫描器发现了 33 笔不寻常的礼来期权交易。</p>
<p>这并不正常。</p>
<p>这些大资金交易者的整体情绪在 39% 看涨和 42% 看跌之间分裂。</p>
<p>在我们发现的所有特殊期权中，有 9 笔看跌期权，总金额为 $1,005,471，24 笔看涨期权，总金额为 $1,892,620。</p>
<h3>价格目标是什么？</h3>
<p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注礼来的价格区间为 $500.0 到 $1600.0。</p>
<h3>分析成交量和未平仓合约</h3>
<p>在今天的交易背景下，礼来的期权平均未平仓合约为 420.12，总成交量达到 954.00。附带的图表描绘了过去 30 天内礼来高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
<h3>礼来过去 30 天的期权成交量和未平仓合约</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767366114_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="期权看涨图表" width="1500" height="800" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767366114_0.png"/></p>
<h3>观察到的最大期权交易：</h3>
<table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th align="right"><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>02/13/26</td>
<td>$13.0</td>
<td>$4.75</td>
<td>$7.65</td>
<td>$910.00</td>
<td>$634.3K</td>
<td align="right">0</td>
<td align="right">805</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>12/18/26</td>
<td>$588.0</td>
<td>$580.0</td>
<td>$582.75</td>
<td>$500.00</td>
<td>$291.3K</td>
<td align="right">27</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$578.05</td>
<td>$571.0</td>
<td>$575.25</td>
<td>$500.00</td>
<td>$287.6K</td>
<td align="right">41</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>01/15/27</td>
<td>$361.0</td>
<td>$357.4</td>
<td>$361.0</td>
<td>$750.00</td>
<td>$180.5K</td>
<td align="right">376</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$236.6</td>
<td>$234.6</td>
<td>$236.6</td>
<td>$900.00</td>
<td>$118.3K</td>
<td align="right">162</td>
<td align="right">6</td>
</tr>
</tbody>
</table>
<h3>关于礼来</h3>
<p>礼来是一家专注于神经科学、心血管代谢、癌症和免疫学的制药公司。礼来的主要产品包括用于癌症的 Verzenio；用于心血管代谢的 Mounjaro、Zepbound、Jardiance、Trulicity、Humalog 和 Humulin；以及用于免疫学的 Taltz 和 Olumiant。</p>
<p>鉴于礼来的近期期权历史，现在适合关注公司本身。我们旨在探讨其当前表现。</p>
<h3>礼来的当前市场状况</h3>
<ul>
<li>LLY 的成交量为 331,417，价格下跌 -0.98%，为 $1064.19。</li>
<li>RSI 指标暗示基础股票可能接近超买状态。</li>
<li>下一次财报预计将在 34 天后发布。</li>
</ul>
<h3>专家对礼来的看法</h3>
<p>在过去一个月中，3 位专家对该股票发布了评级，平均目标价格为 $1222.67。</p>
<p><strong>在短短 20 天内将 $1000 变成 $1270？</strong></p>
<p>一位拥有 20 年经验的期权交易专家揭示了他的单行图表技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。点击这里获取访问权限。
* 在评估中保持一致，来自富国银行的分析师对礼来保持超配评级，目标价格为 $1200。
* 来自 BMO Capital 的分析师对礼来保持跑赢大盘评级，目标价格为 $1200。
* 来自美国银行证券的分析师对礼来保持买入评级，目标价格为 $1268。</p>
<p>期权是一种比仅交易股票更具风险的资产，但它们具有更高的利润潜力。严肃的期权交易者通过每天学习、逐步进出交易、关注多个指标以及密切关注市场来管理这种风险。</p>
<p>如果您想随时了解礼来的最新期权交易，Benzinga Pro 为您提供实时期权交易警报。</p>

礼来

<p>礼来（NYSE: LLY）近期出现了显著的看跌期权活动，共检测到 33 笔异常交易。大型投资者的情绪呈现分歧，39% 看涨，42% 看跌。总交易金额超过 280 万美元，价格目标范围为 500 美元至 1600 美元。目前，LLY 的股价下跌 0.98%，报 1064.19 美元，分析师给出的平均目标价为 1222.67 美元。值得注意的评级包括来自富国银行的 “增持” 和来自 BMO 资本的 “跑赢大盘”，两者的目标价均为 1200 美元。期权交易风险较高，但提供了更大的盈利潜力</p>

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Eli Lilly</strong> (NYSE: LLY).</p>
<div class="lb-trans"><p>拥有大量资金的投资者对 <strong>礼来</strong> (NYSE: LLY) 持悲观态度。</p>
</div><p>And retail traders should know.</p>
<div class="lb-trans"><p>而散户交易者应该知道这一点。</p>
</div><p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<div class="lb-trans"><p>我们今天注意到这一点，当交易出现在我们在 Benzinga 跟踪的公开可用期权历史中时。</p>
</div><p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LLY, it often means somebody knows something is about to happen.</p>
<div class="lb-trans"><p>我们不知道这些是机构还是仅仅是富有的个人。但当 LLY 发生如此重大的事情时，通常意味着有人知道即将发生什么。</p>
</div><p>So how do we know what these investors just did?</p>
<div class="lb-trans"><p>那么我们如何知道这些投资者刚刚做了什么呢？</p>
</div><p>Today, Benzinga's options scanner spotted 33 uncommon options trades for Eli Lilly.</p>
<div class="lb-trans"><p>今天，Benzinga 的期权扫描器发现了 33 笔不寻常的礼来期权交易。</p>
</div><p>This isn't normal.</p>
<div class="lb-trans"><p>这并不正常。</p>
</div><p>The overall sentiment of these big-money traders is split between 39% bullish and 42%, bearish.</p>
<div class="lb-trans"><p>这些大资金交易者的整体情绪在 39% 看涨和 42% 看跌之间分裂。</p>
</div><p>Out of all of the special options we uncovered, 9 are puts, for a total amount of $1,005,471, and 24 are calls, for a total amount of $1,892,620.</p>
<div class="lb-trans"><p>在我们发现的所有特殊期权中，有 9 笔看跌期权，总金额为 $1,005,471，24 笔看涨期权，总金额为 $1,892,620。</p>
</div><h3>What's The Price Target?</h3>
<div class="lb-trans"><h3>价格目标是什么？</h3>
</div><p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $500.0 to $1600.0 for Eli Lilly during the past quarter.</p>
<div class="lb-trans"><p>分析这些合约的成交量和未平仓合约，似乎大玩家在过去一个季度内关注礼来的价格区间为 $500.0 到 $1600.0。</p>
</div><h3>Analyzing Volume &amp; Open Interest</h3>
<div class="lb-trans"><h3>分析成交量和未平仓合约</h3>
</div><p>In today's trading context, the average open interest for options of Eli Lilly stands at 420.12, with a total volume reaching 954.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly, situated within the strike price corridor from $500.0 to $1600.0, throughout the last 30 days.</p>
<div class="lb-trans"><p>在今天的交易背景下，礼来的期权平均未平仓合约为 420.12，总成交量达到 954.00。附带的图表描绘了过去 30 天内礼来高价值交易的看涨和看跌期权的成交量和未平仓合约的变化。</p>
</div><h3>Eli Lilly Option Volume And Open Interest Over Last 30 Days</h3>
<div class="lb-trans"><h3>礼来过去 30 天的期权成交量和未平仓合约</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767366114_0.png" alt="Options Call Chart" original-src="https://www.benzinga.com/files/images/story/2026/1767366114_0.png"/></p>
<h3>Largest Options Trades Observed:</h3>
<div class="lb-trans"><h3>观察到的最大期权交易：</h3>
</div><table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/13/26</td>
<td>$13.0</td>
<td>$4.75</td>
<td>$7.65</td>
<td>$910.00</td>
<td>$634.3K</td>
<td align="right">0</td>
<td align="right">805</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$588.0</td>
<td>$580.0</td>
<td>$582.75</td>
<td>$500.00</td>
<td>$291.3K</td>
<td align="right">27</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$578.05</td>
<td>$571.0</td>
<td>$575.25</td>
<td>$500.00</td>
<td>$287.6K</td>
<td align="right">41</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$361.0</td>
<td>$357.4</td>
<td>$361.0</td>
<td>$750.00</td>
<td>$180.5K</td>
<td align="right">376</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/18/26</td>
<td>$236.6</td>
<td>$234.6</td>
<td>$236.6</td>
<td>$900.00</td>
<td>$118.3K</td>
<td align="right">162</td>
<td align="right">6</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>符号</strong></th>
<th><strong>看跌/看涨</strong></th>
<th><strong>交易类型</strong></th>
<th><strong>情绪</strong></th>
<th><strong>到期日</strong></th>
<th><strong>卖出价</strong></th>
<th><strong>买入价</strong></th>
<th><strong>价格</strong></th>
<th><strong>行权价</strong></th>
<th><strong>总交易价格</strong></th>
<th align="right"><strong>未平仓合约</strong></th>
<th align="right"><strong>成交量</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>看跌</td>
<td>扫描</td>
<td>看涨</td>
<td>02/13/26</td>
<td>$13.0</td>
<td>$4.75</td>
<td>$7.65</td>
<td>$910.00</td>
<td>$634.3K</td>
<td align="right">0</td>
<td align="right">805</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看跌</td>
<td>12/18/26</td>
<td>$588.0</td>
<td>$580.0</td>
<td>$582.75</td>
<td>$500.00</td>
<td>$291.3K</td>
<td align="right">27</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$578.05</td>
<td>$571.0</td>
<td>$575.25</td>
<td>$500.00</td>
<td>$287.6K</td>
<td align="right">41</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>01/15/27</td>
<td>$361.0</td>
<td>$357.4</td>
<td>$361.0</td>
<td>$750.00</td>
<td>$180.5K</td>
<td align="right">376</td>
<td align="right">5</td>
</tr>
<tr>
<td>LLY</td>
<td>看涨</td>
<td>交易</td>
<td>看涨</td>
<td>09/18/26</td>
<td>$236.6</td>
<td>$234.6</td>
<td>$236.6</td>
<td>$900.00</td>
<td>$118.3K</td>
<td align="right">162</td>
<td align="right">6</td>
</tr>
</tbody>
</table>
</div><h3>About Eli Lilly</h3>
<div class="lb-trans"><h3>关于礼来</h3>
</div><p>Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.</p>
<div class="lb-trans"><p>礼来是一家专注于神经科学、心血管代谢、癌症和免疫学的制药公司。礼来的主要产品包括用于癌症的 Verzenio；用于心血管代谢的 Mounjaro、Zepbound、Jardiance、Trulicity、Humalog 和 Humulin；以及用于免疫学的 Taltz 和 Olumiant。</p>
</div><p>In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<div class="lb-trans"><p>鉴于礼来的近期期权历史，现在适合关注公司本身。我们旨在探讨其当前表现。</p>
</div><h3>Present Market Standing of Eli Lilly</h3>
<div class="lb-trans"><h3>礼来的当前市场状况</h3>
</div><ul>
<li>With a volume of 331,417, the price of LLY is down -0.98% at $1064.19.</li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<div class="lb-trans"><ul>
<li>LLY 的成交量为 331,417，价格下跌 -0.98%，为 $1064.19。</li>
<li>RSI 指标暗示基础股票可能接近超买状态。</li>
<li>下一次财报预计将在 34 天后发布。</li>
</ul>
</div><h3>What The Experts Say On Eli Lilly</h3>
<div class="lb-trans"><h3>专家对礼来的看法</h3>
</div><p>In the last month, 3 experts released ratings on this stock with an average target price of $1222.67.</p>
<div class="lb-trans"><p>在过去一个月中，3 位专家对该股票发布了评级，平均目标价格为 $1222.67。</p>
</div><p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<div class="lb-trans"><p><strong>在短短 20 天内将 $1000 变成 $1270？</strong></p>
</div><p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Eli Lilly with a target price of $1200.
* An analyst from BMO Capital persists with their Outperform rating on Eli Lilly, maintaining a target price of $1200.
* An analyst from B of A Securities persists with their Buy rating on Eli Lilly, maintaining a target price of $1268.</p>
<div class="lb-trans"><p>一位拥有 20 年经验的期权交易专家揭示了他的单行图表技术，显示何时买入和卖出。复制他的交易，平均每 20 天获得 27% 的利润。点击这里获取访问权限。
* 在评估中保持一致，来自富国银行的分析师对礼来保持超配评级，目标价格为 $1200。
* 来自 BMO Capital 的分析师对礼来保持跑赢大盘评级，目标价格为 $1200。
* 来自美国银行证券的分析师对礼来保持买入评级，目标价格为 $1268。</p>
</div><p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<div class="lb-trans"><p>期权是一种比仅交易股票更具风险的资产，但它们具有更高的利润潜力。严肃的期权交易者通过每天学习、逐步进出交易、关注多个指标以及密切关注市场来管理这种风险。</p>
</div><p>If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.</p>
<div class="lb-trans"><p>如果您想随时了解礼来的最新期权交易，Benzinga Pro 为您提供实时期权交易警报。</p>
</div>

礼来最新期权趋势的幕后揭秘